Pathways of cell activation in spondyloarthropathies.
The initiating event in cell activation is unknown in most autoimmune diseases. The role of infection is clear in some cases, especially in reactive arthritis; however, there is little evidence of a specific organism in other spondyloarthropathies. Common pathways of cell-cell interaction and activation manifest in inflammation, but subtle differences may exist. The presence of T cells, macrophages, and B-lymphocytes suggest an autoimmune mechanism; the arthritogenic peptide theory has been proposed. Furthermore, the association of spondyloarthropathies with HLA-B27 suggests it may be important in synovial T-cell activation. Other cell types involved in the process of bone and cartilage destruction, including fibroblasts and osteoclasts, may also be activated. Endothelial activation and angiogenesis may be a critical primary event in these diseases. Finally, trauma (physical or psychological) in the form of stress may be an important factor; the nervous system and neuropeptides may play a role in cell activation and initiation of arthritis.
Fearon
U
U
The Department of Rheumatology, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
Veale
D J
DJ
D002455:Cell Division / Q000502:physiology; D018450:Disease Progression; D004730:Endothelium, Vascular / Q000166:cytology / Q000502:physiology*; D006801:Humans; D008264:Macrophages / Q000502:physiology*; D009389:Neovascularization, Pathologic; D010011:Osteocytes / Q000502:physiology*; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D013131:Spine / Q000098:blood supply*; D025242:Spondylarthropathies / Q000209:etiology / Q000503:physiopathology*